CD33 and neoplasm: Conversely, CD33 Db-FM presented a relatively lower density on the tumor cell surface (1 nM) and experienced a 4.5-fold reduction in surface labeling over the same time, possibly explained by receptor-mediated internalization of CD33 Db-FM [48].